Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMV Cytomegalovirus Retinitis”

66 trials

Showing 20 of 66 results

Early research (Phase 1)Study completedNCT00000673
What this trial is testing

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 38
Large-scale testing (Phase 3)Study completedNCT00002377
What this trial is testing

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT00002125
What this trial is testing

Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Astra USA 112
Not applicableStudy completedNCT00002330
What this trial is testing

Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Roche Global Development 280
Testing effectiveness (Phase 2)Study completedNCT00000766
What this trial is testing

CMV Retinitis Retreatment Trial

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT03598452
What this trial is testing

High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

Who this might be right for
Infection ViralUveitis, Posterior
Aier School of Ophthalmology, Central South University 33
Not applicableStudy completedNCT00000799
What this trial is testing

HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT00002142
What this trial is testing

An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Gilead Sciences 100
Early research (Phase 1)Study completedNCT00000668
What this trial is testing

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00000142
What this trial is testing

Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)

Who this might be right for
HIV InfectionsCMV Cytomegalovirus Retinitis
Johns Hopkins Bloomberg School of Public Health 64
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Not applicableStudy completedNCT00001999
What this trial is testing

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
American National Red Cross
Not applicableStudy completedNCT00002015
What this trial is testing

An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Roche Global Development 20
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Not applicableStudy completedNCT00341172
What this trial is testing

The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis

Who this might be right for
AIDS
National Cancer Institute (NCI) 2,232
Testing effectiveness (Phase 2)Study completedNCT00004794
What this trial is testing

Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisAcquired Immunodeficiency Syndrome
National Center for Research Resources (NCRR) 90
Not applicableStudy completedNCT00000905
What this trial is testing

Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT00002187
What this trial is testing

ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Ionis Pharmaceuticals, Inc.
Not applicableStudy completedNCT00000168
What this trial is testing

Longitudinal Study of Ocular Complications of AIDS (LSOCA)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeCytomegalovirus Retinitis
Johns Hopkins Bloomberg School of Public Health 2,392
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation